- Previous Close
107.20 - Open
108.00 - Bid 107.60 x --
- Ask 107.80 x --
- Day's Range
106.40 - 108.00 - 52 Week Range
77.60 - 110.00 - Volume
1,724,242 - Avg. Volume
4,635,083 - Market Cap (intraday)
445.86M - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
9.78 - EPS (TTM)
0.11 - Earnings Date Mar 13, 2025
- Forward Dividend & Yield 0.07 (6.42%)
- Ex-Dividend Date Feb 6, 2025
- 1y Target Est
--
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover. The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly. The Company's dividend policy is to seek to maintain a progressive dividend that is covered by adjusted earnings. On this basis, the target total dividend for the year ending 31 December 2024 is 6.95 pence per share, a 0.18 pence increase over the 6.77 pence in dividends paid per ordinary share for the year ended 31 December 2023. The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.
www.impactreit.uk--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CRT.L
View MorePerformance Overview: CRT.L
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRT.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRT.L
View MoreValuation Measures
Market Cap
444.20M
Enterprise Value
--
Trailing P/E
9.88
Forward P/E
11.52
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.06
Price/Book (mrq)
0.90
Enterprise Value/Revenue
13.01
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
83.04%
Return on Assets (ttm)
4.28%
Return on Equity (ttm)
9.25%
Revenue (ttm)
54.15M
Net Income Avi to Common (ttm)
44.96M
Diluted EPS (ttm)
0.11
Balance Sheet and Cash Flow
Total Cash (mrq)
10.98M
Total Debt/Equity (mrq)
39.12%
Levered Free Cash Flow (ttm)
19.57M